Recently, Santini et al. demonstrated that RANK expression in primary tumors from BC patients is a predictive marker of both the occurrence of BM/bone metastasis and of shorter skeletal disease-free survival [47]. This evidence concerns the gene TNFRSF11A and breast cancer.